Inge E. van Es - Concepedia

Author

Inge E. van Es

University of Amsterdam

Also Known As

I E van Es, I.E. van Es, Inge E van Es, Inge E. van Es

Publications

493

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Amsterdam UMC Location University of Amsterdam Leiden University Medical Center Leiden University University of Cambridge

About

Inge E. van Es is an author at University of Amsterdam specializing in medicine, autoimmunity, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	120
2	Social Sciences	1	1	67
3	Behavioral Sciences	1	1	67
4	Cell Biology	1	1	39
5	Cellular Physiology	1	1	39

Inge E. van Es

Publications

485

Citations

H-Index

Page 1

	Year	Citations
Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis Samuel García, Linda M. Hartkamp, Beatriz Malvar‐Fernández, Arthritis Research & Therapy	2016	104
MuSK myasthenia gravis monoclonal antibodies Maartje G. Huijbers, Dana L.E. Vergoossen, Yvonne E. Fillié‐Grijpma, Neurology Neuroimmunology & Neuroinflammation	2019	86
Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression Chiara Angiolilli, Aleksander M. Grabiec, Bradley S. Ferguson, Annals of the Rheumatic Diseases	2014	82
μ-Opioid Receptors in the Nucleus Accumbens Shell Region Mediate the Effects of Amphetamine on Inhibitory Control But Not Impulsive Choice Joost Wiskerke, Dustin Schetters, Inge E. van Es, Journal of Neuroscience Impulsive BehaviorPsychopharmacologyRat ModelsImpulsivitySocial Sciences	2011	67
Tie2 Signaling Cooperates with TNF to Promote the Pro-Inflammatory Activation of Human Macrophages Independently of Macrophage Functional Phenotype Samuel García, Sarah Krausz, Carmen A. Ambarus, PLoS ONE	2014	49
Btk inhibition suppresses agonist-induced human macrophage activation and inflammatory gene expression in RA synovial tissue explants Linda M. Hartkamp, Jay S. Fine, Inge E. van Es, Annals of the Rheumatic Diseases	2014	44
Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis Maartje G. Huijbers, Jaap J. Plomp, Inge E. van Es, Experimental Neurology Muscle FunctionImmunologyMusk Myasthenia GravisCellular PhysiologyMuscle Weakness	2019	39
A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis Ellen Strijbos, Maartje G. Huijbers, Inge E. van Es, Vaccine VaccinationAutoimmune DiseaseHumoral Immune ResponseTetanus RevaccinationHumoral Response	2017	14

Page 1